HHT (Hereditary Hemorrhagic Telangiectasia) is a genetic disorder that causes malformed blood vessels. HHT affects 1 in 5,000 people. It impacts both males and females of all ages. Ninety percent plus of HHT sufferers have recurring nosebleeds, often multiple times per week.

We provide funding for educational support about HHT as well as BleedCEASE Trial Sample Packs.